HSPG2 and glioblastoma: Other potential ECM components with autophagy-inhibitory functions are the proteoglycans perlecan and lumican, which stood out as slightly but significantly upregulated in miR-7 tumors (not shown), and notably, elevated lumican levels have been linked to improved prognosis and reduced aggressiveness in GBM patients [82].